Programos peržiūra ir programėlės atsisiuntimas

Choose your country or region in order to display more relevant content.

Select

Other country or region

Country

Valoda

Continue

Pacienta informācija

Neatkarīgi no tā, vai drīzumā jums ir jāievieto balons, vai arī jūs pašlaik atrodaties 16 nedēļu programmas vidū, mēs esam šeit, lai palīdzētu jums.

Uzziniet, ko jūs varat sagaidīt katrā svara zaudēšanas ceļojuma solī

Saņemiet atbildes no mūsu svara zaudēšanas ekspertiem

Piekļūstiet saviem datiem un statistikai no lietotnes Allurion

Kā iestatīt savienotos svarus un veselības izsekotāju

Piekļūstiet lietotnei Allurion

Lejupielādējiet lietotni Allurion šodien, lai izsekotu jūsu progresam

Piekļuve šeit

Tehniskais atbalsts Allurion ierīcēm

Lejupielādējiet mūsu bezmaksas resursus jūsu savienotajiem svariem, veselības izsekotājam un mobilajai lietotnei

Lejupielādēt

*As with any medical solution, results may vary from one patient to another, and some patients may not respond to treatment. Please consult a doctor to carefully evaluate the risks and benefits before making your decision.
**Some patients may experience earlier deflation of the Allurion Balloon. The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical intervention. In rare cases, instead of being expelled through the digestive tract, the empty balloon may be vomited out.
***Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a careful review of your medical history. In the case of an extended Allurion Program, your eligibility is reassessed before each placement to ensure you continue to meet the required conditions.

R. Ienca et al. The procedureless ellipse gastric balloon program: Multicenter experience in 1770 consecutive patients. Obes surg. 2020;30(9):3354-3362. Multicenter, prospective, non-randomized, open registry study conducted in patients with overweight or obesity from January 2016 to June 2019 in 19 international obesity centers participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m2 at baseline underwent treatment with the Elipse swallowable gastric balloon, with a monthly visit and a total follow-up of 4 months. 63 patients (3.6%) did not complete the program, and the balloon was removed before 4 months due to intolerance or other adverse effects.
World Health Organization – Key facts on Obesity and overweight (who.int).
European survey finds over three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful – EASO.
This information is extracted from the instructions for use of the Allurion Gastric Balloon System. Version number CS137-02-ENG. If you have any questions regarding this document, please consult your doctor.

Chat with Ally